Online citations, reference lists, and bibliographies.
← Back to Search

Formulation And Investigation Of 5-FU Nanoparticles With Factorial Design-based Studies.

A. Bozkır, O. M. Saka
Published 2005 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This study describes an orthogonal experimental design to optimize the formulation of 5-fluorouracil (5-FU) loaded poly D,L (lactide-co-glycolide) (PLGA) nanoparticles (5FU-NP) by a nanoprecipitation-solvent displacement technique. The type of surfactant, amount of acetone and molecular weight of the polymer with three levels of each factor were selected and arranged in an L18(3(5)) orthogonal experimental table. From the statistical analysis of the data polynominal equations were generated. Optimized formulations have the particle size ranging from 160 to 250 nm. Smallest nanoparticles (161+/-1.22 nm) were obtained using Resomer PLGA 755 and pluronic F-68 with 10 ml acetone amount. Under these conditions the 5-FU entrapment percentage was maximum 78.30%, suggesting 5-FU might be entrapped and adsorbed on the nanoparticle surface. In vitro release of three formulations with maximum drug entrapment efficiency and minimum particle size, were also investigated by release kinetics. According to the determined coefficients, release data fit to Higuchi's diffusion kinetics. The in vitro release of 5FU-NP in phosphate buffered saline (PBS, pH 7.4) is suggested to be controlled by a combination of diffusion with slow and gradual erosion of the particles. Also, the antimicrobial activity was observed even on the end of seventh day with all formulations.
This paper references
10.1016/0378-5173(95)04369-1
In vitro and in vivo evaluation of PLAGA (50/50) microspheres containing 5-fluorouracil prepared by a solvent evaporation method
K. Çiftçi (1996)
Comparison of biodegradable nanoparticles and multiple emulsions (water-in-oil-in-water) containing influenza virus antigen on the in vivo immune response in rats.
A. Bozkır (2004)
10.1016/0014-5793(94)00351-3
Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes
S. Moghimi (1994)
10.1111/j.2042-7158.1990.tb07033.x
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
P. Jani (1990)
10.1016/0378-5173(90)90024-X
Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading
B. Seijo (1990)
Selective delivery of pepleomycin to esophageal lymph nodes by activated carbon particles.
E. Hirao (1993)
10.1016/S0168-3659(97)00106-5
Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.
M. Zambaux (1998)
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard
M. Ferraro (2000)
10.1016/S0939-6411(97)00056-8
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
M. D. Blanco (1997)
10.1248/CPB.25.2410
Evaluation of water in oil and microsphere in oil emulsions as a specific delivery system of 5-fluorouracil into lymphatics.
M. Hashida (1977)
10.1248/CPB.23.3125
Studies on pharmaceutical modification of anticancer agents. II. Enhanced delivery of bleomycin into lymph by emulsions and drying emulsions.
Y. Nakamoto (1975)
10.1111/j.2042-7158.1986.tb03373.x
The Nature of the Oil Phase and the Release of Solutes from Multiple (w/o/w) Emulsions
J. Omotosho (1986)
10.1016/0378-5173(89)90273-1
Release characteristics of bleomycin mitomycin C and 5-fluorouracil from gelatin microspheres
R. Jeyanthi (1989)
10.1016/0928-0987(94)90018-3
Microspheres of 5-fluorouracil using poly(dl-lactic acid): in vitro release properties and distribution in mice after i.v. administration
K. Çiftçi (1994)
10.1023/A:1018908421434
Biodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release
H. Yoo (2004)
10.1016/S0168-3659(96)01588-X
Potential for lymphatic targeting of peptides
S. Muranishi (1997)
10.1016/S0168-3659(97)00048-5
Polymeric prodrugs of 5-fluorouracil
M. Nichifor (1997)
10.1016/0168-3659(93)90103-C
The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery
P. Scholes (1993)
10.1081/DDC-100102197
Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method.
J. Barichello (1999)
Anticancer agents adsorbed by activated carbon particles, a new form of dosage enhancing efficacy on lymphnodal metastases.
A. Hagiwara (1986)
10.1023/A:1018965121222
Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes
H. Harashima (2004)
The influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design
P. Wehrlé (1995)
10.1023/A:1012117531448
Preparation of Biodegradable, Surface Engineered PLGA Nanospheres with Enhanced Lymphatic Drainage and Lymph Node Uptake
A. E. Hawley (2004)
10.1080/10717540490280705
Chitosan Nanoparticles for Plasmid DNA Delivery: Effect of Chitosan Molecular Structure on Formulation and Release Characteristics
A. Bozkır (2004)



This paper is referenced by
10.1016/J.ENCONMAN.2010.09.027
Comparison of indoor air temperatures of different under-floor heating pipe layouts
R. Gao (2011)
10.21007/ETD.CGHS.2013.0190
A series of pharmaceutical technology concepts applied to pediatric formulations
Hao Lou (2013)
10.1007/s13233-019-7119-z
Development and Optimization of Alendronate Sodium Loaded PLGA Nanoparticles by Central Composite Design
U. Oz (2019)
10.2147/IJN.S17386
Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design
Jifu Hao (2011)
10.3109/03639045.2013.789907
Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics
Hao Lou (2014)
10.1016/S1773-2247(07)50007-9
Evaluation of the physicochemical characteristics and activity of various kinds of ciprofloxacin HCl-loaded cationic nanoparticles
K. Dillen (2007)
10.1016/j.ejps.2013.02.004
Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments.
M. Simonoska Crcarevska (2013)
Photophysical characterization and optimization of novel polymer based photosensitizer carrier systems for PDT
Christoph Markschies (2010)
10.1208/s12249-010-9414-z
Development and Statistical Optimization of Solid Lipid Nanoparticles of Simvastatin by Using 23 Full-Factorial Design
Mayank Shah (2010)
10.1080/03602559.2010.482076
The Effect of the Degree of Deacetylation of Chitosan Nanoparticles and its Characterization and Encapsulation Efficiency on Drug Delivery
Hui-Chia Yang (2010)
10.1088/1757-899x/736/2/022011
Application of two level factorial design to study the microbe growth inhibition by pineapple leaves juice
P. N. Y. M. Ridza (2020)
10.1016/j.jsps.2015.02.001
Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles
L R Amruth Kumar (2015)
10.1208/s12249-008-9146-5
5-Fluorouracil-Loaded BSA Nanoparticles: Formulation Optimization and In Vitro Release Study
A. Maghsoudi (2008)
10.1186/s12936-020-03209-5
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
Sileshi Belew (2020)
10.1007/s11095-015-1647-9
A Design of Experiment Study of Nanoprecipitation and Nano Spray Drying as Processes to Prepare PLGA Nano- and Microparticles with Defined Sizes and Size Distributions
C. Draheim (2015)
Makalesi POLYMERIC NANOPARTICLES
S. Derman (2013)
10.1517/17425247.4.5.513
Nucleoside analogue delivery systems in cancer therapy
R. Diab (2007)
10.1002/9781118444726.CH5
Polymeric Drug Delivery Systems for Encapsulating Hydrophobic Drugs
N. Ahmed (2013)
Fabrication of Cyclodextrin Loaded Glimepiride Nanoparticles and Its Evaluation
Jacqulin (2014)
10.1248/CPB.59.272
Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study.
R. C. Nagarwal (2011)
10.1002/APP.29829
Optimization of preparation conditions of carboxymethyl potato starch through orthogonal experimental design
Yinghui Bi (2009)
10.1016/j.ejpb.2012.05.007
Development of a novel probe sonication assisted enhanced loading of 5-FU in SPION encapsulated pectin nanocarriers for magnetic targeted drug delivery system.
R. K. Dutta (2012)
10.17877/DE290R-15560
Particles from preformed polymers as carriers for drug delivery
K. Miladi (2014)
10.21608/AJPS.2013.7097
APPLICATION OF 23 FULL-FACTORIAL DESIGN FOR DEVELOPMENT AND OPTIMIZATION OF BIOCOMPATIBLE, BIODEGRADABLE SOLID LIPID NANOPARTICLES CONTAINING CURCUMIN
H. Dawaba (2013)
10.1109/TNB.2016.2612340
Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil
A. Ashour (2016)
10.3390/molecules13102340
Novel Strategies to Improve the Anticancer Action of 5-Fluorouracil by Using Drug Delivery Systems
José L. Arias (2008)
10.1155/2017/8214120
A New Method for the Determination of Sucrose Concentration in a Pure and Impure System: Spectrophotometric Method
A. Borji (2017)
10.1016/j.biomaterials.2013.12.045
SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy.
Xibo Ma (2014)
10.1007/S00396-009-2131-Z
Protein-loaded PLGA–PEO blend nanoparticles: encapsulation, release and degradation characteristics
M. J. Santander-Ortega (2010)
10.1109/ICONN.2006.340611
Anionic Eudragit nanoparticles as carriers for oral administration of peptidomimetic drugs
R. Pereira (2006)
10.1016/j.colsurfb.2016.08.004
Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
F. Sadeghi (2016)
Development and Optimization of Biocompatible, Biodegradable Solid Lipid Nanoparticles Containing
Curcumin Hamdy (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar